Zhejiang Xianju Pharmaceutical Co Ltd (002332.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE100000K64

Price
8.91 CNY
Market cap
8.81 bn CNY
P/E (2025)
19.60
P/S (2025)
2.34
Dividend yield
3.37 %
Net margin
11.96 %
Return on equity (ROE)
7.45 %
Return on assets (ROA)
6.19 %

Zhejiang Xianju Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue4.00 bn CNY3.76 bn CNY
Gross profit2.26 bn CNY2.30 bn CNY
Operating income678.21 m CNY490.12 m CNY
EBIT617.42 m CNY540.49 m CNY
Net income397.18 m CNY449.64 m CNY
Diluted EPS – continuing operations0.40 CNY0.45 CNY

Full history since 2006, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Zhejiang Xianju Pharmaceutical Co Ltd

Zhejiang Xianju Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid raw materials and preparations in China and internationally. The company offers cortical steriod, gynecology and family planning, respiratory, and dermatological drugs, as well as anaesthetic and muscle relaxants; and active pharmaceutical ingredients and intermediates. It is also involved in the provision of contract development and manufacturing organization; contract manufacturing organization; technical; technology development; and inspection and testing services. The company was founded in 1972 and is headquartered in Xianju, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 03.11.2026. Details in the risk notice.